PRESS RELEASES
More events are coming soon.
Keyword Search
- 03/04/14Summary ToggleSanten and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology
- 02/03/14Summary ToggleTRACON Pharmaceuticals Initiates Phase 1b Study of TRC105 in Patients with Advanced Soft Tissue Sarcomae
- 10/22/13Summary ToggleTRACON Pharmaceuticals Announces TRC105 Data Presented at the 2013 AACR‐NCI‐EORTC International Conference
- 09/23/13Summary ToggleTRACON Pharmaceuticals Initiates Phase 1b Study of TRC105 in Patients with Metastatic Renal Cell Carcinoma
- 05/20/13Summary ToggleTRACON Pharmaceuticals Announces TRC105 Clinical Trials, Abstract Presentations at 2013 ASCO Annual Meeting
- 04/17/13Summary ToggleTRACON Pharmaceuticals Announces Publication of Mechanism of Action of TRC105, a Novel Anti‐Angiogenic Antibody
- 12/06/11
- 04/20/11
- 10/25/10
- 04/26/10